Integra LifeSciences gets $10.3 million contract with U.S. Department of DefenseStaff writer ▼ | March 11, 2016
Integra LifeSciences Holding said that through its partnership with Buffalo Supply, it has received a five-year, $10.3 million contract with the U.S. Department of Defense (DoD).
Health and defense Specialty Surgical Solutions and Orthopedics & Tissue Technology
The contract is specified for the Defense Logistics Agency (DLA) Medical Electronic Catalogue (ECAT). The DLA purchases approximately $4.5 billion of medical material each year for DoD facilities around the world, as well as other U.S. federal agencies.
"We are delighted to be a part of the ECAT system. Integra’s products are used with great success in U.S. Military medical treatment facilities, and many have been integrated into medical procedures developed and applied by military surgeons practicing across the globe.
"ECAT provides a quicker and more efficient means for all U.S. Military medical treatment facilities to get access to our life-changing and, in many instances, life-saving technology, where and when they need it," said Paul Gonsalves, Integra’s chief commercial officer.
"This contract offers Integra a greater opportunity to provide more of our medical technology and solutions to the brave men and women in uniform, worldwide."
The ECAT contract includes a wide variety of Integra products designed to meet the ever-changing challenges faced by military clinicians when bringing life-saving care to troops who have suffered a wide range of battlefield injuries.
These unique solutions include Integra Dermal Regenerative Template (IDRT), the only FDA and PMA approved product for the treatment of third-degree burns and scar contractures, along with a multitude of other Regenerative Wound Care products used in the treatment of mild to severe soft tissue injuries. ■